title: [Perspective of obesity pharmacotherapy].
abstract: Obesity is a very common disease with very difficult treatment. Most patients are not able to change their behaviour. Most hopeful for the future is a safe pharmacotherapy which could be widely used. In this review, old and potentially new drugs decreasing weight are mentioned (centrally acting anorectics, orlistat, incretine analogues and gliphlozines). Review of newly in U.S.A used antiobesitics is also mentioned. Finally potentially new principles of obesity pharmacotherapy are enumerated.
authors: Stěpán
authors: S
authors: Svačina
authors: Petr
authors: P
authors: Sucharda
authors: Zuzana
authors: Z
authors: Stránská
authors: Martin
authors: M
authors: Matoulek
mesh_terms: D019440:Anti-Obesity Agents / Q000627:therapeutic use; D001067:Appetite Depressants / Q000627:therapeutic use*; D006801:Humans; D007783:Lactones / Q000627:therapeutic use; D009765:Obesity / Q000188:drug therapy*; D000077403:Orlistat
chemical_list: D019440:Anti-Obesity Agents; D001067:Appetite Depressants; D007783:Lactones; D000077403:Orlistat